560 related articles for article (PubMed ID: 15790548)
1. Anemia of chronic disease: pathophysiology and laboratory diagnosis.
Thomas C; Thomas L
Lab Hematol; 2005; 11(1):14-23. PubMed ID: 15790548
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic plot: a concept for identifying different states of iron deficiency and monitoring the response to epoetin therapy.
Thomas C; Kirschbaum A; Boehm D; Thomas L
Med Oncol; 2006; 23(1):23-36. PubMed ID: 16645227
[TBL] [Abstract][Full Text] [Related]
3. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r-HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics.
Cotes PM; Pippard MJ; Reid CD; Winearls CG; Oliver DO; Royston JP
Q J Med; 1989 Feb; 70(262):113-37. PubMed ID: 2594953
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of soluble transferrin receptor and ferritin in iron deficiency and chronic disease.
Marković M; Majkić-Singh N; Subota V
Scand J Clin Lab Invest; 2005; 65(7):571-6. PubMed ID: 16271988
[TBL] [Abstract][Full Text] [Related]
6. [Soluble transferrin receptor and erythropoietin in chronic disease anemia with or without iron deficiency].
Díaz de Domingo NB; Lardo MM; Gasparini S; Grinspon D; Cantenys N; Carbia CD; Merelli A; Sánchez Avalos JC
Medicina (B Aires); 2001; 61(5 Pt 1):552-6. PubMed ID: 11725764
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients.
Chang J; Bird R; Clague A; Carter A
Pathology; 2007 Jun; 39(3):349-53. PubMed ID: 17558864
[TBL] [Abstract][Full Text] [Related]
8. Iron requirements in erythropoietin therapy.
Eschbach JW
Best Pract Res Clin Haematol; 2005 Jun; 18(2):347-61. PubMed ID: 15737895
[TBL] [Abstract][Full Text] [Related]
9. Iron management during recombinant human erythropoietin therapy.
Van Wyck DB
Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):9-13. PubMed ID: 2757026
[TBL] [Abstract][Full Text] [Related]
10. Double diagnostic meaning of serum transferrin receptor in hemodialysis patients: two case reports.
Passanante S; Diquattro M; Greco V; Li Cavoli G; Bono L; Palma B; Scola S; Faraci C; Rotolo U; Menozzi I
Lab Hematol; 2004; 10(2):61-4. PubMed ID: 15224760
[TBL] [Abstract][Full Text] [Related]
11. Monitoring iron status in end-stage renal disease patients on hemodialysis.
Rafi A; Karkar A; Abdelrahman M
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
[TBL] [Abstract][Full Text] [Related]
12. High serum transferrin receptor level in anemia of chronic disorders indicates coexistent iron deficiency.
Das Gupta A; Abbi A
Am J Hematol; 2003 Mar; 72(3):158-61. PubMed ID: 12605386
[TBL] [Abstract][Full Text] [Related]
13. Reticulocyte hemoglobin measurement--comparison of two methods in the diagnosis of iron-restricted erythropoiesis.
Thomas L; Franck S; Messinger M; Linssen J; Thomé M; Thomas C
Clin Chem Lab Med; 2005; 43(11):1193-202. PubMed ID: 16232085
[TBL] [Abstract][Full Text] [Related]
14. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency.
Thomas C; Thomas L
Clin Chem; 2002 Jul; 48(7):1066-76. PubMed ID: 12089176
[TBL] [Abstract][Full Text] [Related]
15. Reticulocyte hemoglobin content.
Mast AE; Blinder MA; Dietzen DJ
Am J Hematol; 2008 Apr; 83(4):307-10. PubMed ID: 18027835
[TBL] [Abstract][Full Text] [Related]
16. [The biochemical and hematological assessment of iron metabolism].
Nathanson S; Deschênes G; Bensman A
Arch Pediatr; 1999 Nov; 6(11):1199-204. PubMed ID: 10587746
[TBL] [Abstract][Full Text] [Related]
17. Erythropoiesis activity, iron availability and reticulocyte hemoglobinization during treatment with hemodialysis and in subjects with uremia.
Schoorl M; Schoorl M; Nubé MJ; Bartels PC
Clin Lab; 2006; 52(11-12):621-9. PubMed ID: 17175894
[TBL] [Abstract][Full Text] [Related]
18. Monitoring the content of reticulocyte hemoglobin (CHr) as the progression of anemia in nondialysis chronic renal failure (CRF) patients.
Tsuchiya K; Saito M; Okano-Sugiyama H; Nihei H; Ando M; Teramura M; Iwamoto YS; Shimada K; Akiba T
Ren Fail; 2005; 27(1):59-65. PubMed ID: 15717636
[TBL] [Abstract][Full Text] [Related]
19. [How do we optimally evaluate iron stores in dialyzed patients treated with erythropoiesis stimulating agent?].
Kessler M; Salignac S; Aimone-Gastin I
Nephrol Ther; 2006 Sep; 2 Suppl 4():S261-5. PubMed ID: 17373268
[TBL] [Abstract][Full Text] [Related]
20. Serum transferrin receptor.
Skikne BS
Am J Hematol; 2008 Nov; 83(11):872-5. PubMed ID: 18821709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
